Transmedics Group Inc
Company Overview
TransMedics Group, Inc. is a commercial-stage medical technology company that develops and commercializes organ care systems to revolutionize organ transplantation. Their primary product is the Organ Care System (OCS), which maintains organs in a near-physiologic state outside the human body, enabling longer preservation times and improved donor organ utilization for transplantation.
The company's technology platforms include OCS Heart, OCS Lung, and OCS Liver, which are designed to address the current limitations of cold storage preservation. These systems optimize organ preservation and assessment, potentially increasing the utilization of donor organs for transplantation.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| Sept. 30, 2024 | $108.76m | $108.45m | - | $3.62m | 0.00% | 3.34% |
| June 30, 2024 | $114.31m | $105.42m | - | $3.62m | 0.00% | 3.44% |
| March 31, 2024 | $96.85m | $88.03m | - | $3.6m | 0.00% | 4.09% |
Company Impact
Help us evaluate Transmedics Group Inc's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.